| Home | E-Submission | Sitemap | Contact Us |  
Korean J Clin Oncol. 2006;2(3): 21-29.
Recommendation for Chemotherapeutic Drugs in Stomach Cancer and its Clinical Application
Wook Kim
Department of Surgery, College of Medicine, Catholic University, Korea
위암의 권고안과 실제 임상 적용
가톨릭대학교 의과대학
Corresponding Author: Wook Kim ,Tel: +82-32-340-7022, Fax: +82-32-340-2669, Email: kimwook@catholic.ac.kr
Received: May 13, 2006;  Accepted: June 14, 2006.
Share :  
Every year about 20,000 people are diagnosed with stamach cancer in Korea. And among them, about 40% patients was known to be an early gastric cancer, curable with surgery alone. Therefore, though patients with advanced gastric cancer undergo radical surgery, the tumor has recurred or matastasized frequently, making the treatment process more difficult. In the past, stomach cancer in general was thought to be unresponsive to chemotherapy, but recent clinical studies are providing otherwise. Accordingly, following the health care payment standards stated in the National Health Insurance, the government on September 1, 2006 has announced specific articles concerning health care payment of medications chosen by the minister of the Department of Health and Welfare (chemotherapy, antiemetics, cancer painkillers) prescribed to cancer patients. Regarding t the anticancer drugs and especially those that have been developed recently(irinotecan, docetaxel, capecitabine, S-1, oxaliplatin), it was felf that the 2nd. line anticancer drugs, which are usually administered in combination with 5-FU/LV or cisplatin, are not giving the patient the best care possible. However, considering the present economic status of Korea and the indivisual circumstances of the cancer patients, the recommendations have relieved many limitations of cancer drug uses of the past, and although the selection of drugs are not completely satisfactory, and has helped that patients with inoperable or recurrent gastric cancer. Thus, with results from active clinical trials both domestic and abroad, progressive revisions of the present recommendation for anticancer drug use will not only increase satisfaction of the treatment in both doctors and patients but also serve as a foundation in constructing a better anticancer drug use recommendation.
Keywords: chemotherapy | recommendation | gastric cancer
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Editorial Office
101-3304 Brownstone Seoul, 464 Cheongpa-ro, Jung-gu, Seoul 04510, Korea
TEL : +82-2-393-2114   FAX : +82-2-393-1649   E-mail : office@kjco.org

Copyright© Korean Society of Surgical Oncology.                Developed in M2PI
About |  Browse Articles |  Current Issue |  For Authors and Reviewers